MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?

R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia (Catania, Italy)

Meeting: 2016 International Congress

Abstract Number: 478

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Epidemiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the burden of non-motor symptoms (NMS) among patients affected by Parkinson’s disease (PD) with respect to the general population and to evaluate possible gender differences in their occurrence.

Background: Several studies have demonstrated a high frequency of NMS in PD patients, often showing a higher prevalence among women. Nonetheless, NMS are common also in the aging population and only few studies have evaluated the possible gender effect among PD patients with respect to the general population.

Methods: The FRAGAMP study is a large multicenter case-control study involving five Movement Disorder centers located in Central-Southern Italy. Patients affected by PD diagnosed according to the Gelb’s diagnostic criteria were consecutively enrolled in the study. Control population was gathered from among healthy people who accompanied non-Parkinsonian patients and who were matched by age and area of residence. All subjects underwent a face-to-face interview and a neurological examination performed by trained neurologists. Presence of NMS was investigated in both cases and controls using a standardized questionnaire exploring the following domains: sleep, mood and cognition, gastrointestinal, urinary and sexual dysfunction; cognitive impairment and depression were assessed using the Mini Mental State Examination and the Hamilton Depression Rating Scale respectively.

Results: The FRAGAMP study enrolled a total of 585 cases and 481 controls. Sleep, gastrointestinal and sexual dysfunction were the most frequent NMS in both groups. Among PD patients, all NMS investigated were more frequent among women excepting for sexual dysfunction. However,when compared with the control population, logistic regression stratified by sex showed a higher risk of developing all NMS excepting for urinary dysfunction among men with ORs ranging from 2.52 (95% CI 1.54 – 4.11) to 37.3 (95% CI 5.12-271.40).

Conclusions: In agreement with data from literature, the majority of NMS in PD are more frequent among women. However, when compared with a control population, men showed a higher risk of developing NMS, probably due to a different background risk.

To cite this abstract in AMA style:

R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia. Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them? [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/gender-effect-on-non-motor-symptoms-in-parkinsons-disease-are-men-more-at-risk-for-most-of-them/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gender-effect-on-non-motor-symptoms-in-parkinsons-disease-are-men-more-at-risk-for-most-of-them/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley